About Celon Laboratories Private Limited
Data last updated:
Celon Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Znz Pharma 2 Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 January 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2001PTC036097. Its GSTIN is 36AACCG1654P1ZA (Telangana). The company holds 23 GST registrations, of which 11 are active.
The company has an authorised share capital of ₹233.1 Cr and a paid-up capital of ₹65.1 Cr. It was formerly known as Medvin Labs Private Limited and Galen Labs Private Limited. It is led by director Ajay Bhatia (Managing Director).
Its last annual general meeting (AGM) was held on 28 November 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.2 Aleap Industrial Estate Gajularamaram, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹148.17 Cr, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹43.73 Cr (net margin -29.5%) and EBITDA of -₹20.55 Cr (EBITDA margin -13.9%). Revenue has declined at a compounded annual rate (CAGR) of 31% over three years and 6% over five years.
The company has about 535 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Celon Laboratories. As per MCA filings, the company has open charges of ₹46 Cr and satisfied charges of ₹701.32 Cr on record. Court records list 63 cases involving the company, including 29 filed by the company and 34 filed against it; 11 cases are pending. The company has 28 deals on record (14 secondary share transfers, 12 funding rounds, 1 buyback), with disclosed funding of ₹353.97 Cr; the latest was in September 2022. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 4 smaller; the largest is Leben Laboratories Private Limited with revenue of ₹149.37 Cr. The company has 15 MSME Form 1 returns on record between 2018 and 2024, listing 4,436 overdue payments to 117 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website celonlabs.com.
Company details
Name history
Celon Laboratories has undergone 3 name changes throughout its history. The company was previously known as Medvin Labs Private Limited, Galen Labs Private Limited, and Celon Laboratories Limited. The current legal name is Celon Laboratories Private Limited.
| Company Name | Status |
|---|---|
| Celon Laboratories Private Limited | Current |
| Medvin Labs Private Limited | Previous |
| Galen Labs Private Limited | Previous |
| Celon Laboratories Limited | Previous |
CIN history
Celon Laboratories has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24232TG2001PTC036097, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2001PTC036097 | Current |
| U24232AP2001PLC036097 | Previous |
| U24232TG2001PLC036097 | Previous |
Contact details
Celon Laboratories Private Limited's registered office is in Hyderabad, Telangana. Its website is celonlabs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No.2 Aleap Industrial Estate Gajularamaram, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Celon Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Celon Laboratories operates one associated brand: Celon Laboratories. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Oncology and critical care pharmaceuticals are manufactured and marketed. | celonlabs.com |
Business activity
The main business activity of Celon Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Celon Laboratories Private Limited, buy the company report.
Financials of Celon Laboratories Private Limited
FY 2025 filings availableCelon Laboratories Private Limited reported revenue of ₹148.17 Cr (down 7% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years, including a 7% fall in the latest year. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹20.55 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹43.73 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -13.9% | ||||
| Net Profit Margin | -29.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Celon Laboratories Private Limited, buy the company report.
Board of directors and KMP of Celon Laboratories Private Limited
Celon Laboratories Private Limited currently reports 1 director and 1 key managerial person. 25 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Kumar Upputhalla | Company Secretary | 02 Apr 2025 | 1 Years 6 Months | Current |
| Ajay Bhatia | Managing Director | 02 May 2024 | 2 Years 5 Months | Current |
Peer comparison
Celon Laboratories Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Leben Laboratories Private Limited | ₹149.37 Cr (FY 2025) | 15.0% | Akola, Maharashtra, India | |||
| Bafna Pharmaceuticals Limited | ₹148.6 Cr (FY 2025) | -5.0% | Chennai, Tamil Nadu, India | |||
| Celon Laboratories Private Limitedthis company | ₹148.17 Cr (FY 2025) | -₹43.73 Cr | -29.5% | -7.0% | 535 | Hyderabad, Telangana, India |
| Canton Laboratories Private Limited | ₹147.08 Cr (FY 2025) | 26.0% | Vadodara, Gujarat, India | |||
| Murli Krishna Pharma Private Limited | ₹146.68 Cr (FY 2025) | -21.0% | Pune, Maharashtra, India | |||
| Raman & Weil Private Limited | ₹145.87 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Pulse Pharmaceuticals Private Limited | ₹145.08 Cr (FY 2024) | -1.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Celon Laboratories Private Limited, buy the company report.
Auditor
Celon Laboratories Private Limited is audited by PRICE WATER HOUSE CHARTERED ACCOUNTANTS LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRICE WATER HOUSE CHARTERED ACCOUNTANTS LLP | FY 2023 | 012754N/N500016 |
Shareholding
The shareholding of Celon Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Celon Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Feb 2024 | 100877187 | Others | ₹46 Cr | Open | |
| 06 Jul 2017 | 100114120 | Others | ₹500 Cr | Satisfied | |
| 27 Feb 2015 | 10553049 | Export Import Bank of India | ₹119 Cr | Satisfied | |
| 25 Jun 2012 | 10364980 | Kotak Mahindra Bank Limited | ₹3.65 Cr | Satisfied | |
| 27 Dec 2011 | 10326848 | Icici Bank Limited | ₹18.2 Cr | Satisfied |
To see the full charge records of Celon Laboratories Private Limited, buy the company report.
Total charge records: 18 View all charges
Deals & funding
Celon Laboratories Private Limited has 28 deals on record (14 secondary share transfers, 12 funding rounds, 1 buyback), with disclosed funding of ₹353.97 Cr; the latest was in September 2022.
Deals on record (5 of 28)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2022 | Buyback | ₹22.81 Cr | |
| Jul 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 4 individuals |
| Sep 2018 | Secondary share transfer | Undisclosed | Buyer: Radhanga Real Estate Developers Private Limited Seller: Others-Celon Laboratories Private Limited |
| Aug 2018 | Funding round | ₹6.1 Cr | Investors: 2 individuals |
| Dec 2015 | Secondary share transfer | Undisclosed | Buyer: Aruna Finecap Private Limited , 3 individuals Seller: Celon Laboratories Limited Employee Welfare Trust, an individual |
To see the full deal history of Celon Laboratories Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Celon Laboratories Private Limited has 63 court cases on record: 29 filed by Celon Laboratories, 34 filed against it. 11 cases are pending and 52 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 34 | 5 | 5 |
| District courts | 24 | 24 | 6 |
| NCLT | 5 | 5 | 0 |
Cases on record (5 of 63)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Gauhati High Court | Writ petition | Filed by the company against Assam Medical Services Corporation Limited and 1 other | Disposed |
| NCLT, Ahmedabad | Court case (Rst.A(CompaniesAct)) | Filed against the company by Being Sure Life Sciences Private Limited | Disposed |
| NCLT, Ahmedabad | Court case (MA(CompaniesAct)) | Filed against the company by Being Sure Life Sciences Private Limited | Disposed |
| NCLT, Ahmedabad | Interim or miscellaneous application | Filed against the company by Being Sure Life Sciences Private Limited | Disposed |
| NCLT, Ahmedabad | Company petition | Filed against the company by Being Sure Life Sciences Private Limited | Disposed |
To see the full case history of Celon Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Celon Laboratories Private Limited was last rated by Indiarating on 10 Nov 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Indiarating | 10 Nov 2022 |
To see the full credit ratings and regulatory alerts of Celon Laboratories Private Limited, buy the company report.
MSME payment delays
Celon Laboratories Private Limited has 15 MSME Form 1 returns on record between 2018 and 2024, listing 4,436 overdue payments to 117 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 117)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| SS Plasto Pack Technologies | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Celon Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Celon Laboratories Private Limited has a workforce of 535 employees on its EPFO records as of Nov 15, 2024, across 1 active EPFO establishment.
GST
Celon Laboratories has 23 GST registrations: 11 active and 12 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCG1654P1ZA | Telangana | Active | 01 Jul 2017 |
| 09AACCG1654P2Z6 | Uttar Pradesh | Active | 01 Jul 2017 |
| 24AACCG1654P1ZF | Gujarat | Active | 01 Jul 2017 |
| 27AACCG1654P1Z9 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Celon Laboratories Private Limited, buy the company report.
Recent activity
Celon Laboratories Private Limited has 28 board changes on record since 2008: 4 appointments and 24 cessations. The latest: Ravi Kumar Upputhalla was appointed as Company Secretary on 02 Apr 2025.
62 earlier events are in the company report.
Frequently asked questions
Celon Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 January 2001 (25+ years old) and is registered under CIN U24232TG2001PTC036097.
Celon Laboratories has 2 current directors and KMP:
- Ajay Bhatia - Managing Director
- Ravi Kumar Upputhalla - Company Secretary
The latest financial statements of Celon Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 November 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Celon Laboratories is 36AACCG1654P1ZA, registered in Telangana. The company has 23 GST registrations in all, of which 11 are active and 12 are cancelled or inactive. Other active GSTINs include 09AACCG1654P2Z6 (Uttar Pradesh), 24AACCG1654P1ZF (Gujarat), 27AACCG1654P1Z9 (Maharashtra).
The CIN (Corporate Identification Number) of Celon Laboratories is U24232TG2001PTC036097. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Celon Laboratories has 63 court cases on record: 29 filed by the company and 34 filed against it. 11 are pending. Most are in the high courts.
Celon Laboratories was incorporated on 23 January 2001, making it 25+ years old. It is registered with the Registrar of Companies, Hyderabad.
Celon Laboratories has 28 deals on record (14 secondary share transfers, 12 funding rounds, 1 buyback), with disclosed funding of ₹353.97 Cr; the latest was in September 2022.
The peers of Celon Laboratories by revenue are Leben Laboratories Private Limited, Bafna Pharmaceuticals Limited, Canton Laboratories Private Limited, Murli Krishna Pharma Private Limited, Raman & Weil Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ravi Kumar Upputhalla was appointed as Company Secretary on 02 Apr 2025. Shyam Mundada ceased to be Additional Director on 29 Aug 2024. Ajay Bhatia was appointed as Managing Director on 02 May 2024. Celon Laboratories has 28 board changes on record in total.
Celon Laboratories has 15 MSME Form 1 returns on record between 2018 and 2024, listing 4,436 overdue payments to 117 micro and small suppliers. The latest return was filed on 25 Apr 2024.
Celon Laboratories can be reached through the website celonlabs.com. Its registered office is in Hyderabad, Telangana, India.